Concepedia
Statistics
Publications
29
Citations
3.2K
H-Index
22
Active since
1992
Affiliations
Wayne State University(Current)
The Barbara Ann Karmanos Cancer Institute
The University of Texas MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic in Arizona
Mary Varterasian is an author at Wayne State University specializing in oncology, medicine, and pharmacology.
Publications per year
1992–2023
Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer
John J. Rinehart, Alex A. Adjei, Patricia LoRusso et al. · Journal of Clinical Oncology · 2004 · 639 citations
Medicine, Oncology, Pharmacology +16
First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study
Ryan J. Sullivan, Jeffrey R. Infante, Filip Jankú et al. · Cancer Discovery · 2017 · 418 citations
Medicine, Oncology, Pharmacology +14
Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies
Patricia LoRusso, Alex A. Adjei, Mary Varterasian et al. · Journal of Clinical Oncology · 2005 · 399 citations
Medicine, Oncology, Pharmacology +17
Intratumoral injection of <i>Clostridium novyi</i> -NT spores induces antitumor responses
Nicholas J. Roberts, Linping Zhang, Filip Jankú et al. · Science Translational Medicine · 2014 · 395 citations · Full text
Medicine, Microbiology, Oncology +13
Intratumoral Injection of <i>Clostridium novyi</i> -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors
Filip Jankú, Halle Huihong Zhang, Abdulmohammad Pezeshki et al. · Clinical Cancer Research · 2020 · 155 citations · Full text
Pharmacy, Oncology, Toxicology +14
1–5 of 29